SCHEMBL4776840

SCHEMBL4776840

Cn1c(-c2ccc(Cl)cc2)nc2c(=O)[nH]c(Cc3c(F)ccc(F)c3Cl)nc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
ALDH1A1 P00352 4/20 0.41
HPGD P15428 3/20 0.41
KDM4E B2RXH2 2/20 0.41
PKM P14618 1/20 0.41
ADORA3 P0DMS8 1/20 0.34
ADORA2A P29274 1/20 0.34
ADORA1 P30542 1/20 0.34
MAPT P10636 1/20 0.34
DHFR P00374 2/20 0.34
LMNA P02545 1/20 0.34
GAA P10253 1/20 0.34
RECQL P46063 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
ADORA2B P29275 1/20 0.33
POLB P06746 1/20 0.33
HTT P42858 1/20 0.33
PARP1 P09874 1/20 0.33
TNKS O95271 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4774517 0.90 MEN1 (0.42) KMT2AMEN1ALDH1A1HPGDKDM4E
SCHEMBL4777055 0.89 MEN1 (0.44) KMT2AMEN1ALDH1A1HPGDKDM4E
SCHEMBL4772366 0.84 MEN1 (0.43) KMT2AMEN1ALDH1A1HPGDKDM4E
SCHEMBL4772481 0.84 MEN1 (0.43) KMT2AMEN1ALDH1A1HPGDKDM4E
SCHEMBL4767017 0.81 POLB (0.40) KMT2AALDH1A1HPGDKDM4EADORA3
SCHEMBL4776863 0.81 PIM1 (0.34) KMT2AMEN1PARP1
SCHEMBL4776947 0.80 RNASEH1 (0.49) KMT2AMEN1ALDH1A1HPGDKDM4E
SCHEMBL4767126 0.79 HPGD (0.39) KMT2AMEN1ALDH1A1HPGDKDM4E
SCHEMBL4770146 0.79 PIM1 (0.39) KMT2AMEN1ALDH1A1HPGDMAPT
SCHEMBL4776202 0.78 ALDH1A1 (0.39) KMT2AMEN1ALDH1A1HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1881988-A1 2,3-SUBSTITUTED FUSED BICYCLIC PYRIMIDIN-4(3H)-ONES MODULATING THE FUNCTION OF THE VANILLOID-1 RECEPTOR (VR1) MERCK SHARP & DOHME LTD. (GB) 2008-01-30 EP disclosed
WO-2006122200-A1 2,3-SUBSTITUTED FUSED BICYCLIC PYRIMIDIN-4(3H)-ONES MODULATING THE FUNCTION OF THE VANILLOID-1 RECEPTOR (VR1) MERCK SHARP & DOHME LIMITED (GB) 2006-11-16 WO disclosed